Related Experiment Video

Updated: Jul 1, 2025

Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models
03:42

Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models

Published on: September 27, 2024

1.4K

Role of STAT3 in pancreatic cancer

Zachary Hamel1, Sierra Sanchez1, David Standing1

  • 1Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA.

Exploration of Targeted Anti-Tumor Therapy
|March 11, 2024
PubMed

Insights

Signal transducer and activator of transcription 3 (STAT3) is crucial in pancreatic cancer development and progression. Targeting STAT3 offers a promising therapeutic strategy for pancreatic ductal adenocarcinoma (PDAC).

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Pancreatic cancer, particularly pancreatic ductal adenocarcinoma (PDAC), presents significant global health challenges with incomplete understanding of its molecular drivers.
  • The signal transducer and activator of transcription (STAT) family, especially STAT3, is implicated in various cancer processes, but its specific role in PDAC requires further elucidation.

Purpose of the Study:

  • To summarize the current understanding of STAT3's role in pancreatic cancer, focusing on its activation in cancer cells and the tumor microenvironment (TME).
  • To review the therapeutic potential of targeting STAT3 in pre-clinical and clinical settings for PDAC treatment.

Main Methods:

  • Comprehensive literature review of existing research on STAT3 in pancreatic cancer.
  • Analysis of STAT3 activation mechanisms within PDAC cells and the TME.
  • Evaluation of pre-clinical and clinical trial data for STAT3-targeted therapies in PDAC.

Main Results:

  • STAT3 plays a critical role in PDAC tumorigenesis, progression, immune evasion, drug resistance, and stemness.
  • STAT3 signaling influences the tumor microenvironment (TME), impacting cancer's overall trajectory.
  • The importance of STAT3 in PDAC may exceed that of KRAS, highlighting its therapeutic significance.

Conclusions:

  • STAT3 is a pivotal molecular player in pancreatic ductal adenocarcinoma, influencing multiple facets of the disease.
  • Targeting STAT3 presents a highly attractive and promising therapeutic avenue for developing novel treatments for pancreatic cancer.
  • Further investigation into STAT3's multifaceted roles and therapeutic targeting is warranted for improved patient outcomes.
Keywords:
Signal transducer and activator of transcriptionpancreatic cancertumor microenvironment

More Related Videos

An Orthotopic Resectional Mouse Model of Pancreatic Cancer07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

10.6K
Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

11.2K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K